Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramucirumab with cyclophosphamide and vinorelbine in cancer (Phase 1–2, Japan)
jRCT2080225151Phase 2Recruiting
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of ramucirumab in cancer. Started Apr 2020; status: recruiting.
02
Drugs
ramucirumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080225151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225151.